A Study to Evaluate a Range of Dose Levels and Vaccination Intervals of Ad26.COV2.S in Healthy Adults and Adolescents

NCT04535453 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

635

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: Ad26.COV2.S
OTHER: Placebo

Sponsor

Janssen Vaccines & Prevention B.V.